XFOR
Price:
$4
Market Cap:
$377.28M
X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candidate, XOLREMDI (also known as mavorixafor), is an orally administered, small-molecule antagonist specifically designed to target the chemokine receptor CXCR4. This compound is currently undergoing Phase 3 clinical trials for the management of WHIM syndrome, a rare immunodeficiency characterized by symptoms such as warts, hypogammaglobulinemia, recurrent infections, and myelokathexis. To broaden its global presence, the company has entered into several licensing agreements: A partnership with Abb...[Read more]
Industry
Biotechnology
IPO Date
2017-11-16
Stock Exchange
NASDAQ
Ticker
XFOR
According to X4 Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.18. This represents a change of 39.59% compared to the average of 7.29 of the last 4 quarters.
The mean historical Current Ratio of X4 Pharmaceuticals, Inc. over the last ten years is 6.07. The current 10.18 Current Ratio has changed 16.67% with respect to the historical average. Over the past ten years (40 quarters), XFOR's Current Ratio was at its highest in in the March 2020 quarter at 15.34. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
6.07
Median
6.02
Minimum
0.47
Maximum
13.68
Discovering the peaks and valleys of X4 Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.47%
Maximum Annual Current Ratio = 13.68
Minimum Annual Increase = -84.14%
Minimum Annual Current Ratio = 0.47
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 10.16 | 197.65% |
| 2024 | 3.41 | -36.10% |
| 2023 | 5.34 | -7.36% |
| 2022 | 5.76 | -8.02% |
| 2021 | 6.27 | -10.12% |
| 2020 | 6.97 | -49.05% |
| 2019 | 13.68 | 1.06% |
| 2018 | 1.18 | -84.14% |
| 2017 | 7.45 | 1.47% |
| 2016 | 0.47 | -62.27% |
The current Current Ratio of X4 Pharmaceuticals, Inc. (XFOR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
6.30
5-year avg
6.19
10-year avg
6.07
X4 Pharmaceuticals, Inc.’s Current Ratio is greater than Aligos Therapeutics, Inc. (2.56), greater than Karyopharm Therapeutics Inc. (1.08), greater than FibroGen, Inc. (3.61), greater than Mersana Therapeutics, Inc. (1.39), less than Kezar Life Sciences, Inc. (24.46), greater than Senti Biosciences, Inc. (1.04), greater than INmune Bio, Inc. (4.24), greater than Skye Bioscience, Inc. (1.78), less than OnKure Therapeutics, Inc. (13.78), greater than Tempest Therapeutics, Inc. (0.74),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.56 | $32.67M | |
| 1.08 | $215.30M | |
| 3.61 | $36.69M | |
| 1.39 | $145.36M | |
| 24.46 | $53.86M | |
| 1.04 | $25.24M | |
| 4.24 | $32.97M | |
| 1.78 | $27.67M | |
| 13.78 | $57.43M | |
| 0.74 | $5.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like X4 Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like X4 Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is X4 Pharmaceuticals, Inc.'s Current Ratio?
How is the Current Ratio calculated for X4 Pharmaceuticals, Inc. (XFOR)?
What is the highest Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?
What is the 3-year average Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?
What is the 5-year average Current Ratio for X4 Pharmaceuticals, Inc. (XFOR)?
How does the current Current Ratio for X4 Pharmaceuticals, Inc. (XFOR) compare to its historical average?